Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Rubin

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Journal of Counseling Psychology|August 8, 2024
Interdependent stigma of seeking mental health services: Examining a new scale across eight countries/regionsDavid L Vogel, Nan Zhao, Carlos A Vidales, et al.
The Lancet. Oncology|February 1, 2023
Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology CommissionRaffaella Casolino, Amber L Johns, Melanie Courtot, et al.
BJU International|April 10, 2010
Anatomical retro-apical technique of synchronous (posterior and anterior) urethral transection: a novel approach for ameliorating apical margin positivity during robotic radical prostatectomyAshutosh K Tewari, Abhishek Srivastava, Kumaran Mudaliar, et al.
Science (New York, N.Y.)|November 17, 2022
Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasionQiqun Zeng, Sadegh Saghafinia, Agnieszka Chryplewicz, et al.
Cancer Research|December 21, 2013
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug developmentDong Lin, Alexander W Wyatt, Hui Xue, et al.
Pathology|December 5, 2014
Active surveillance for prostate cancer: the role of the pathologistBrett Delahunt, Elizabeth Hammond, Lars Egevad, et al.
Archives of Pathology & Laboratory Medicine|August 6, 2014
The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer FoundationMahul B Amin, Daniel W Lin, John L Gore, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findingsUrsula M Vogl, Tomasz M Beer, Ian D Davis, et al.
Nature Communications|December 22, 2021
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancerNeha Singh, Varune R Ramnarine, Jin H Song, et al.
Scientific Reports|July 4, 2025
Pan-cancer immune and stromal deconvolution predicts clinical outcomes and mutation profilesBhavneet Bhinder, Verena Friedl, Sunantha Sethuraman, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of Counseling Psychology|August 8, 2024
Interdependent stigma of seeking mental health services: Examining a new scale across eight countries/regionsDavid L Vogel, Nan Zhao, Carlos A Vidales, et al.
The Lancet. Oncology|February 1, 2023
Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology CommissionRaffaella Casolino, Amber L Johns, Melanie Courtot, et al.
BJU International|April 10, 2010
Anatomical retro-apical technique of synchronous (posterior and anterior) urethral transection: a novel approach for ameliorating apical margin positivity during robotic radical prostatectomyAshutosh K Tewari, Abhishek Srivastava, Kumaran Mudaliar, et al.
Science (New York, N.Y.)|November 17, 2022
Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasionQiqun Zeng, Sadegh Saghafinia, Agnieszka Chryplewicz, et al.
Cancer Research|December 21, 2013
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug developmentDong Lin, Alexander W Wyatt, Hui Xue, et al.
Pathology|December 5, 2014
Active surveillance for prostate cancer: the role of the pathologistBrett Delahunt, Elizabeth Hammond, Lars Egevad, et al.
Archives of Pathology & Laboratory Medicine|August 6, 2014
The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer FoundationMahul B Amin, Daniel W Lin, John L Gore, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findingsUrsula M Vogl, Tomasz M Beer, Ian D Davis, et al.
Nature Communications|December 22, 2021
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancerNeha Singh, Varune R Ramnarine, Jin H Song, et al.
Scientific Reports|July 4, 2025
Pan-cancer immune and stromal deconvolution predicts clinical outcomes and mutation profilesBhavneet Bhinder, Verena Friedl, Sunantha Sethuraman, et al.
Pageof 9